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E-mail address: kay.ohlendieck@nuim.ie (K. OhlenDuchennemuscular dystrophy is themost frequent neuromuscular disorder of childhood. Although this x-
linkedmuscle disease is extremely progressive, not all subtypes of skeletalmuscles are affected in the same
way.While extremities and trunkmuscles are drasticallyweakened, extraocularmuscles areusually spared
in Duchenne patients. In order to determine the global protein expression pattern in these naturally pro-
tected muscles we have performed a comparative proteomic study of the established mdx mouse model
of x-linkedmuscular dystrophy. Fluorescence difference in-gel electrophoretic analysis of 9-week-old dys-
trophin-deficient versus age-matchednormal extraocularmuscle, using apH4–7gel range, identifiedout of
1088 recognized protein spots amoderate expression change in only seven protein species. Desmin, apoli-
poproteinA-I binding protein and perilipin-3were found to be increased and gelsolin, gephyrin, transaldol-
ase, andacyl-CoAdehydrogenasewere showntobedecreased inmdxextraocularmuscles. Immunoblotting
revealed a drastic up-regulation of utrophin, comparable levels of b-dystroglycan and key Ca2+-regulatory
elements, and an elevated concentration of small stress proteins inmdx extraocularmuscles. This suggests
that despite the lack of dystrophin only a limited number of cellular systems are perturbed inmdx extraoc-
ularmuscles, probably due to the substitution of dystrophin by its autosomal homolog. Utrophin appears to
prevent the loss of dystrophin-associated proteins and Ca2+-handling elements in extraocular muscle tis-
sue. Interestingly, the adaptive mechanisms that cause the sparing of extraocular fibers seem to be closely
linked to an enhanced cellular stress response.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Dystrophinopathies are characterized by a primary deficiency in
the Dp427 isoform of the membrane cytoskeletal protein dystro-
phin [1] and secondary abnormalities in sarcolemmal stability,
ion homeostasis, cellular signaling, excitation–contraction cou-
pling, and numerous metabolic pathways [2]. Severely progressive
Duchenne muscular dystrophy (DMD) and the more benign Becker
muscular dystrophy are allelic muscle diseases and are classified
according to changes in the expression level and/or size of dystro-
phin [3]. The loss in Dp427 triggers the drastic reduction in sarco-
lemmal glycoproteins, such as sarcoglycans and dystroglycans
(DG) which in turn weakens the integrity of the plasmalemma
and leads to an increased frequency of membrane rupturing in dys-
trophic muscle tissues [4]. Since the Dp427-associated glycopro-ll rights reserved.
strin; cvHsp, cardiovascular
esis; DG, dystroglycan; DMD,
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dieck).tein complex links the extracellular matrix protein laminin and
the subsarcolemmal actin membrane cytoskeleton in healthy
muscle fibers, the reduced presence of the DG-subcomplex is be-
lieved to play a central role in the degeneration of dystrophic mus-
cles. However, not all subtypes of skeletal muscles are affected in
the same way in x-linked muscular dystrophy. For example, intrin-
sic laryngeal and certain distal muscle fibers, as well as extraocular
muscle (EOM), are protected from a severely degenerative pheno-
type in dystrophic organisms [5–11]. Although the contractile
efficiency of EOM is weakened in various muscle-related patholo-
gies, such as myasthenia gravis, myasthenic syndromes, botulism,
and myotonia congenita [12–14], they are usually spared in DMD
patients [15–17].
Therefore, the characterization of these naturally protected
muscles may lead to the identification of constitutive properties
or adaptive mechanisms that cause the sparing of EOM in dystro-
phinopathies [17]. The histological, biochemical, and physiological
profile of EOM is markedly different from other skeletal muscles
[18–21]. During myogenesis, the protein factors responsible for
specifying pre-myogenic progenitor cells in EOM seem to be
distinct from those in the trunk [22]. EOM represent a unique
muscle allotype that controls the movements of the eye. Usually
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is an exception to this general rule of skeletal muscle physiology.
EOM is capable of fast contraction patterns, but is also extremely
fatigue-resistance [23]. The coordinated action of six EOMs, i.e.
Musculus rectus superior, M. rectus inferior, M. rectus medial, M.
rectus lateral,M. obliquus superior, andM. obliquus inferior, enables
the eyeball to move about its vertical, horizontal, and anteroposte-
rior axis. The complex excitation–contraction–relaxation cycle of
EOM ranges from slow vergence and pursuit movements to rapid
saccades. Hence, based on their unique physiological properties
and unusual anatomical structure, many myologists consider
EOM as a separate class of skeletal muscles [24].
Since Dp427-deficient EOM does not appear to be affected in a
major way, we have carried out a mass spectrometry (MS)-based
proteomic comparison of normal versus mdx preparations. The
mdxmouse represents an established animal model of DMD, which
exhibits severe muscle degeneration in the diaphragm, segmental
necrosis in leg muscles, and a mild phenotype in EOM [25]. Proteo-
mic profiling of Dp427-deficient leg and diaphragmmuscles has re-
vealed drastic changes in the expression levels of adenylate kinase,
the luminal Ca2+-binding protein calsequestrin (CSQ), the cytosolic
Ca2+-binding protein regucalcin, and the cardiovascular heat shock
protein (cvHsp), as well as a large number ofmetabolic and contrac-
tilemuscleproteins, as recently reviewedbyLewiset al. [2].Here,we
have used fluorescence difference in-gel electrophoresis (DIGE), one
of the most powerful comparable techniques available in modern
biochemistry [26], to study potential changes in protein expression
levels in Dp427-deficient versus normal EOM preparations. The
identification of only moderate changes in a few select proteins
agrees with the notion of a naturally protected phenotype. Impor-
tantly, immunoblotting showed an enhanced abundance of stress
proteins in mdx EOM, as well as an elevated concentration of the
autosomal dystrophin homolog utrophin of 395 kDa (Up395), a
comparable density of b-DG and rescued levels of CSQ. Hence, natu-
rally protected mdx EOM appears to escape fiber degeneration due
to Dp427 substitution by Up395 and a prevention of downstream
pathophysiological alterations.2. Materials and methods
2.1. Chemicals and materials
Chemicals and materials for DIGE analysis were obtained from
Amersham Biosciences/GE Healthcare, Little Chalfont, Bucking-
hamshire, UK. For peptide mass fingerprinting, sequencing grade-
modified trypsin was purchased from Promega (Madison, WI,
USA). Chemiluminescence substrate and protease inhibitors were
from Roche Diagnostics (Mannheim, Germany). Primary antibodies
were obtained from Cambridge Biosciences, Cambridge, UK, (SPA-
835 to Hsp90; SPA-801 against Hsp25), HyTest Ltd., Turku, Finland
(PCV60 against cvHSP), Sigma Chemical Company, Dorset, UK (pAb
L-9393 to laminin), Vision Biosystems Novocastra, Newcastle upon
Tyne, UK (NCL-a-BCrys to aBC; NCL-b-DG to b-DG), Thermo Fisher
Scientific Inc., Rockford, IL, USA (MA3-913 against CSQ; MA3-912
to SERCA1), Abcam Ltd., Cambridge, UK (ab14730 to mitochondrial
ATP synthase) and Santa Cruz Biotechnology, Santa Cruz, CA, USA
(sc-15377 to Up395). All secondary antibodies were purchased
from Chemicon International (Temecula, CA). All other chemicals
used were of analytical grade and purchased from Sigma Chemical
Company, Dorset, UK.
2.2. Dystrophic muscle samples
The mdx mouse is an established and widely employed animal
model of x-linked muscular dystrophy with a point mutation in thedystrophin gene [25]. Mildly affected EOM and severely dystrophic
diaphragm muscle from male 9-week-old mdx mice and normal
tissues from age-matched C57 mice were obtained from the Biore-
source Unit of NUI Maynooth [7]. Mice were kept under standard
conditions and all procedures were performed in accordance with
Irish guidelines on the use of animals for scientific experiments.
Animals were sacrificed by cervical dislocation and muscle tissues
quickly removed and quick-frozen in liquid nitrogen [27].
2.3. Preparation of crude muscle extracts
For the biochemical analysis of crude EOM and diaphragm
extracts, three dystrophic and three age-matched normal muscle
specimenswere pulverized by grinding tissue pieces in liquid nitro-
gen using a mortar and pestle. Ground muscle was then solubilized
in lysis bufferwith the ratio of 100 mgwetweight to1 ml lysis buffer
(7 M urea, 2 M thiourea, 4% CHAPS, 2% IPG buffer pH4–7, 2% (w/v)
DTT). The lysis buffer containeda freshlypreparedprotease inhibitor
cocktail [27]. EOM protein samples for DIGE analysis were placed in
buffer containing only the above listed concentrations of urea, thio-
urea, and CHAPS. Following gentle rocking for 30 min, suspensions
were centrifuged at 4 C for 20 min at 20,000g and the protein con-
centration determined [28].
2.4. Fluorescence DIGE analysis
Optimized fluorescence labeling and electrophoretic separation
conditions, as recommended by Karp and Lilley [29], were em-
ployed to determine potential differences in the expression pattern
of the accessible part of the soluble proteome from control versus
dystrophic EOM. Labeling was carried out with 200 pmol of Cy3
fluor dye per 25 lg protein [26]. An internal pooled standard of
every sample was prepared with the Cy5 fluor. Labeled samples
were vortexed and incubated for 30 min on ice in the dark. The
reaction was quenched with 10 mM lysine on ice for 10 min [27].
First dimension isoelectric focusing with pH 4–7 strips and second
dimension slab gel electrophoresis was performed with 50 lg pro-
tein per gel, as previously described in detail [28].
2.5. Protein visualization and data analysis
A Typhoon Trio variable mode imager form Amersham Biosci-
ences/GE Healthcare (Little Chalfont, Bucks., UK) was used to visu-
alize CyDye-labeled EOM proteins. Images of Cy3-labeled muscle
proteins were analyzed with Progenesis Samespots software ver-
sion 3.2.3 from NonLinear Dynamics (Newcastle upon Tyne, UK)
and normalized against their corresponding Cy5 image. All gels
were then aligned to a master reference image. Following detection
of two-dimensional spots, gels were grouped into EOM images ver-
sus control images and analyzed to determine significant differ-
ences in protein spot density. An ANOVA score of 0.5 was
required for spots to be included in the subsequent statistical anal-
ysis. All significantly changed spots were visually checked on the
aligned gels and then identified by MS analysis.
2.6. Identification of EOM proteins
Protein identification via electrospray ionization LC–MS/MS
analysis was carried out as recently described in detail [28]. Refer-
ence gels were prepared with 400 lg of protein and a 1:1 mix of
dystrophic to normal muscle complements. Preparative gels were
stained with the fluorescent dye Ruthenium II Bathophenanthro-
line Disulfonate Chelate and two-dimensional protein spots of
interest were excised using the automated Ettan spot picker sys-
tem from Amersham Biosciences (Little Chalfont, Bucks., UK). Pro-
tein spots were digested by trypsin [27] and peptide mixtures were
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electrospray ionization (Agilent Technologies, Santa Clara, CA, USA)
on a 10 min gradient of 5–100% acetonitrile/0.1% formic acid with a
post run of 1 min [28]. Separation of peptides was performed with
a nanoflow Agilent 1200 series system, equipped with a Zorbax
300SB C18 lm, 4 mm 40 nl pre-column. Mobile phases used were
(A) 0.1% formic acid, (B) 50% acetonitrile and 0.1% formic acid. Sam-
ples (8 ll) were loaded onto the enrichment column with capillary
flow rate set at 4 ll/min with a mix of A:B at a ratio of 19:1. Elution
was carried out with the nano pump flow rate set at 0.6 ll/min.
Database searches were carried out using Mascot MS/MS Ion
search. Criterion for each search was set at (i) species Mus muscu-
lus, (ii) two missed cleavages by trypsin, (iii) variable modification:
oxidation of methionine, (iv) fixed modification: carboxymethyla-
tion of cysteines, and (v) mass tolerance of precursor ions ± 2 Da
and product ions ±1 Da [28].1
2
3
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7
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Fig. 2. DIGE analysis of mdx EOM tissue. Shown is a Cy5-labeled master gel of crude
tissue extracts from EOM tissue covering the pH 4–7 range. Protein spots with a
moderately changed expression in mdx preparations are marked by circles and are
numbered 1–7. See Table 1 for a detailed listing of these EOM-associated proteins
with a changed abundance in the mdx mouse. The pH-values of the first dimension
gel system and molecular-mass standards (in kDa) of the second dimension are
indicated on the top and on the left of the panels, respectively.2.7. Immunoblot analysis
One-dimensional immunoblotting was used to determine the
fate of select EOM and diaphragm proteins in the mdx animal mod-
el. Gel electrophoretic separation and transfer was carried out with
a Mini-Protean II electrophoresis and transfer system from Bio-Rad
Laboratories (Hemel-Hempstead, Herts, UK). Muscle proteins were
transferred to nitrocellulose for 70 min at 100 V and at 4 C. Block-
ing of membranes was achieved with a milk protein solution (5%
(w/v) fat-free milk powder in 0.9% (w/v) NaCl, 50 mM sodium
phosphate, pH 7.4) for 1 h. Incubation with sufficiently diluted pri-
mary antibody was carried out overnight with gentle agitation.
Nitrocellulose sheets were washed and then incubated for 1 h with
secondary peroxidase-conjugated antibodies, diluted in blocking
solution [27]. Immuno-decorated bands were visualized using
chemiluminescence substrate (Roche Diagnostics, Mannheim, Ger-
many). Densitometric scanning of immunoblots was performed
using ImageJ (NIH).A
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Fig. 1. Two-dimensional gel electrophoretic analysis of normal versus mdx EOM tissue.
(C) EOM tissue, as well as Cy5-labeled gels containing pooled standards (B, D). DIGE imag
and molecular-mass standards (in kDa) of the second dimension are indicated on the to3. Results
Since EOMtissues exhibit a uniquelymild phenotype in an other-
wise dystrophic organism, we performed a comparative proteomic
analysis of normal versusmdx preparations. For the optimizedDIGE
analysis of normal versusmdx extracts fromEOM,we have followed
the recommendations of Karp and Lilley [29]. Fig. 1 illustrates repre-
sentative two-dimensional gels of Cy3-labeled normal and dystro-
phic EOM tissue and corresponding Cy5-labeled pooled standards.Cy5
Cy5
4 5 6 7
pH 
B
D
Pooled standard
Pooled standard
Shown are Cy3-labeled gels of total extracts from normal (A) and dystrophic mdx
es are shown for the pH 4–7 range. The pH-values of the first dimension gel system
p and on the left of the panels, respectively.
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the help of a Typhoon Trio variable imager and Progenesis 2-D anal-
ysis software. Overall, 1088 distinct muscle protein species were
recognized in slab gels with an isoelectric focusing range of pH 4–
7. We employed this pH-range in the first dimensional separation
step since previous gel electrophoretic studies have identified the
majority of muscle proteins in this region [2].
An analytical master gel is shown in Fig. 2. Moderate expression
changes were found in seven protein species. These muscle-associ-
ated proteins are marked and numbered 1–7 in the Cy5-labeled
gel, so that it is possible to correlate MS-identified protein species,
listed in Table 1, with distinct two-dimensional spots of altered
density in mdx EOM preparations. Electrospray ionization
LC–MS/MS analysis was performed to unequivocally identify the
changed EOM-associated proteins. The information listed in Table
1 lists the spot number, protein name, protein ID, number of
matched peptides, matched peptide sequences, percentage se-Table 1
List of DIGE-identified proteins with a changed abundance in 9-week-old extraocular mus
Spot
No.
Protein name Matched peptide sequence Protein
Accessio
1 Desmin, muscle-specific
intermediate filament
FASEANGYQDNIAR gi|33563
LLEGEESR
2 Apolipoprotein A-I binding
protein
AYPPTSMSK gi|21553
LFGYQPTIYYPK
RPNKPLFTGLVTQCQK
EPFHSILSVLSGLTVPIASIDIPSGWDVEK
GNPSGIQPDLLISLTAPK
3 Perilipin-3 TLTTAAVSTAQPILSK gi|13385
LEPQIATASEYAHR
SAMTSGVQSVMGSR
VGQMVISGVDR
AQETLQQLTSVLGLMESVK
TPQDAEKDPAKPEQVEAR
4 Gelsolin, cytosolic DSQEEEKTEALTSAK gi|90508
5 Gephyrin GSQECFQFILPALPHAIDLLR gi|14867
DTASLSTTPSESPR
LSTASCPTPK
AFITVLEMTPVLGTEIINYR
VLAQDVYAK
GEVVDVMVIGR
6 Transaldolase MESALDQLK gi|33859
LGGPQEEQIK
LFVLFGAEILK
LSFDKDAMVAR
RLIELYK
LIELYK
LSSTWEGIQAGK
ILDWHVANTDKK
SYEPQEDPGVK
TIVMGASFR
ALAGCDFLTISPK
LLGELLK
7 Acyl-CoA dehydrogenase KLTDIGIR gi|31982
IFSSEHDIFR
KFFQEEVIPHHTEWEK
FFQEEVIPHHTEWEK
QGLLGINIAEK
FIPQMTAGK
SGSDWILNGSK
VFITNGWLSDLVIVVAVTNR
SPAHGISLFLVENGMK
AQDTAELFFEDVR
LPANALLGEENK
GFYYLMQELPQER
LLIAELAISACEFMFEETR
TVAHIQTVQHK
AFVDSCLQLHETK
VQPIYGGTNEIMKquence coverage, the relative molecular mass, pI-value, Mascot
score, and fold change of individual proteins affected by deficiency
in Dp427. MS analysis identified the increased proteins as the mus-
cle-specific intermediate filament protein desmin (spot 1), apolipo-
protein A-I binding protein (spot 2) and perilipin-3 (spot 3) and the
decreased proteins as cytosolic gelsolin (spot 4), gephyrin (spot 5),
transaldolase (spot 6), and acyl-CoA dehydrogenase (spot 7).
In order to further characterize the EOM phenotype, compara-
tive immunoblotting was carried out. The immunoblot analysis
shown in Fig. 3 revealed a drastic up-regulation of Up395, compa-
rable levels of b-DG and CSQ, and an elevated concentration of
stress proteins in mdx EOM preparations. Immuno-decoration
experiments clearly illustrated that the expression of the dystro-
phin-associated glycoprotein b-DG is drastically reduced in the se-
verely degenerative mdx diaphragm, but of comparable levels in
mdx EOM tissue (Fig. 3D and E). The same is true for the luminal
ion-binding protein CSQ (Fig. 3J and K). The concentration of thecle from the MDX mouse model of Duchenne muscular dystrophy.
n No.
Peptides
matched
%
Coverage
Molecular
mass (kDa)
Isoelectric
point (pI)
Mascot
score
Fold
change
250| 2 4 53.5 5.2 51 +2.1
309| 5 30 31.3 7.6 65 +1.8
312| 6 21 47.3 5.4 204 +1.5
| 1 2 81.1 5.5 92 1.4
0669| 6 11 82.0 5.4 139 1.7
640| 12 33 37.5 6.6 147 1.8
520| 16 45 48.3 8.3 321 1.9
A Laminin B Laminin
D β-DG E β-DG
J CSQ K CSQ
F Up395
H SERCA1 I αBC
L cvHsp
O Hsp25
C ATP synthase
G SERCA1
N Hsp90M Hsp90
1   2 3 4 3       4
Diaphragm 
muscle
Extraocular 
muscle
Extraocular 
muscle
Fig. 3. Immunoblotting survey of mdx EOM tissue. Shown are representative
immunoblots with expanded views of immuno-decorated bands labeled with
antibodies to laminin (A, B), ATP synthase (C), b-DG (D, E), Up395 (F), SERCA1 (G, H),
aBC (I), CSQ (J, K), cvHsp (L), Hsp90 (M, N), and Hsp25 (O). Lanes 3 and 4 represent
normal and mdx EOM preparations, respectively. For comparative purposes, lanes 1
and 2 show normal versus mdx diaphragm preparations, respectively.
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SERCA1 pump appear not to be changed in a major way in mdx
mice (Fig. 3A–C, G and H). Immunolabeling of the Up395 isoform
of utrophin confirmed the results of previous studies and showed
a marked increase of this autosomal homolog of Dp427 in EOM
(Fig. 3F). An immunoblotting survey of key stress proteins demon-
strated a drastic increase of essential Hsp elements in mildly dys-
trophic EOM preparations. The expression of the small stress
proteins Hsp25, aB-crystallin (aBC) and cvHsp was elevated in
Dp427-deficient EOM tissue (Fig. 3F–I, L and O). In contrast to de-
creased levels of Hsp90 in the dystrophic diaphragm, this large
stress protein was shown to be increased in mdx EOM (Fig. 3M
and N).
4. Discussion
As compared to non-fluorescent protein dye approaches, the
application of fluorescent CyDyes has decisively improved thedynamic range of protein coverage in comparative proteomic stud-
ies [26,29]. We have therefore used the highly accurate quantita-
tive DIGE technique for the analysis of the mildly affected EOM
from the mdx model of DMD. In other subtypes of skeletal muscles,
the deficiency in Dp427 causes drastic downstream alterations [2].
Proteomic studies have clearly established a generally perturbed
protein expression pattern in mdx diaphragm muscle [27]. It is
therefore crucial to employ an extremely sensitive biochemical
method in order to be able to detect minor changes in a naturally
protected phenotype of dystrophinopathy. Since the fluorescent
DIGE technique enables multiple protein samples to be separated
on the same two-dimensional gel, potential artifacts due to gel-
to-gel variations are greatly reduced [26]. Hence, DIGE analysis
suggests itself as an ideal analytical tool to conduct a comparative
investigation into the proteomic changes in mdx EOM versus nor-
mal EOM preparations. The proteomic findings presented here
agree with the idea that EOM tissue is only marginally affected
by the loss in Dp427.
A moderate change in abundance in seven EOM-associated pro-
teins, as shown here by DIGE analysis, is in stark contrast to major
alterations in 35 diaphragm proteins, as previously shown by MS-
based studies [2,27]. The approximately 2-fold increase in muscle-
specific desmin is an interesting finding, since it supports the
hypothesis that the loss in Dp427 is partially compensated in EOM
tissue by strengthening the intermediate filament network. High
levels of desmin might stabilize the small diameter EOM fibers and
thereby protect them from extensive contraction-induced injury in
the absence of Dp427. The higher concentration of apolipoprotein
A-I binding protein and perilipin-3 suggests an increased utilization
of lipid metabolism. Apolipoprotein A-I binding protein interacts
with apolipoprotein A-I, a crucial constituent of high-density lipo-
protein, and is involved in cholesterol efflux mechanisms. Perili-
pin-3 is a lipid droplet-associated protein that functions as a
protective coating against lipases. An increased level of both pro-
teins might support the alteredmetabolic needs of Dp427-deficient
EOMfibers. Thedecreased levels of gelsolin, gephyrin, transaldolase,
and acyl-CoA dehydrogenase have probably an effect on structural
and metabolic mechanisms. Gelsolin is an actin-binding element
that regulates actin filament dynamics and gephyrin is a tubulin-
binding protein involved in clustering of glycinergic and GABAergic
receptors. Hence, a reduced density in these two binding proteins
might affect actin-based cytoskeletal stability and trigger a certain
degree of post-synaptic disturbances inDp427-deficient EOMfibers.
Lower levels of transaldolase and acyl-CoA dehydrogenase indicate
moderate changes in metabolite utilization. Transaldolase repre-
sents a non-oxidative enzyme of the pentose phosphate pathway
and links this metabolic system to glycolysis. Acyl-CoA dehydroge-
nase is a crucialmitochondrial enzyme involved in fatty acidmetab-
olism. Decreased densities of these two enzymes might therefore
impair key metabolic processes, including the glycolytic pathway,
and fatty acid b-oxidation.
In contrast to the above discussed moderate changes in struc-
tural and metabolic elements as determined by DIGE analysis,
immunoblotting demonstrated on the one hand the rescue of key
muscle proteins in mdx EOM and on the other hand a drastic up-
regulation of proteins belonging to the hsp family of molecular
chaperones. These alterations were probably not detected by pro-
teomics due to the low abundance of these proteins in conven-
tional two-dimensional gels. Interestingly, the drastic increase in
Up395 in Dp427-deficient EOM tissue is associated with compara-
ble levels of the crucial dystrophin-associated glycoprotein b-DG
and the luminal Ca2+-binding protein CSQ. Both proteins are
greatly reduced in the dystrophic diaphragm and are believed to
be major pathophysiological factors in DMD [2,30]. The secondary
loss in b-DG causes the disintegration of sarcolemmal stability and
subsequent Ca2+-dependent necrotic changes in muscular
C. Lewis, K. Ohlendieck / Biochemical and Biophysical Research Communications 396 (2010) 1024–1029 1029dystrophy. Low levels of CSQ seem to exacerbate abnormal cyto-
solic Ca2+-handling by impairing luminal Ca2+-buffering in the dys-
trophic sarcoplasmic reticulum. These pathological alterations
appear not to be present in mdx EOM tissue [31], which agrees
with the previously reported resistance of dystrophic EOM fibers
to Ca2+-induced muscle degeneration [15].
The drastic increase in molecular chaperones suggests that mdx
EOM is capable of sustained cellular stress responses, involving
both low- and high-molecular-mass Hsp elements. Since small
Hsps are especially associated with the repair of the cytoskeletal
network in skeletal muscle [2], the up-regulation of Hsp25, aBC,
and cvHspmight be linked to the DIGE-determined increase in des-
min. In general, stress proteins facilitate the stabilization or elimi-
nation of misfolded proteins or peptide clusters in order to prevent
the deleterious accumulation of non-functional protein aggregates.
Chaperone activity probably plays an important role in the rescue
mechanisms that are intrinsic to EOM fibers.
In conclusion, this proteomic and biochemical study clearly
showed that the mild phenotype of mdx EOM is associated with (i)
only a limited number of metabolic and structural systems being
perturbed, (ii) a drastic increase in Up395 and a concomitant rescue
of sarcolemmal b-DG, (iii) comparable levels of key Ca2+-handling
proteins, and (iv) a drastic increase in molecular chaperones. Thus,
the up-regulation of Hsps and the rescue of the luminal Ca2+-uptake
apparatus inmdxEOMtissue, aswell as the extra-junctional expres-
sion of Up395, are probably crucial for preventing severe muscular
dystrophy. This makes these proteins potential pharmacological
targets for the development of future therapies to treat DMD. In
addition, the small diameter and limited load bearing of EOM fibers
might also be critical factors that render this subtype of skeletal
muscle extremely resistant to cellular degeneration.
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